Developer docs
API playgroundTry for free, no card

Search company profiles

Webster Equity Partners

Full company profile

uuid0000g8l

Namestring
Webster Equity Partners
Legal namestring
Webster Equity Partners, L.P.
Company typeenum
Private
Founded yearint
2003
Descriptiontext

Webster Equity Partners is a Waltham, Massachusetts-based private equity firm founded in 2003 by Donald Steiner that invests exclusively in the branded consumer and healthcare services sectors, with current strategy focused entirely on healthcare. The firm operates a control-investor model, targeting profitable healthcare companies with $20 million to $200 million in revenue and $5 million to $20 million+ EBITDA at entry, typically as the first institutional capital provider. Its portfolio spans more than 25 current companies across risk adjustment (Advantmed), behavioral health (Discovery Behavioral Health, Oceans Healthcare), hospice and home health (Bristol Hospice, Honor), specialty pharmacy (Belmar Pharma Solutions), clinical research (CenExel), medical devices (Orthofeet), radiopharmaceutical CDMO (PharmaLogic), fertility (Pinnacle Fertility), physician practice management (One GI, CVAUSA, Medrina), and adjacent services, with a stated goal of growing portfolio companies to $100M+ EBITDA.

The firm earns revenue through traditional private equity fund management, collecting management fees and carried interest on six successive flagship funds that have grown from $10.5 million (Fund I, 2003) to $1.8 billion (Fund VI, March 2026), with total assets under management of $10.1 billion as of December 31, 2025. Webster supports portfolio companies with Webster Operating Executives, a senior advisory bench drawn from prior CEO/CFO/COO roles at companies including Ralph Lauren, Gap, Guess, BCBG, Bain Capital, Morgan Stanley, Independence Blue Cross, and UnitedHealth Group. Go-to-market is direct and relationship-driven: deal flow sourced through proprietary outreach, healthcare executive networks, and banker relationships, while capital is raised privately from institutional limited partners through confidential offering memoranda and an LP portal.

The firm employs 11-50 staff across its Waltham headquarters and a secondary Palm Beach office, maintains a SEC-registered investment adviser entity (Webster Equity Partners, L.P.), and has rebranded in 2019 from "Webster" to "Webster Equity Partners" to reflect its healthcare specialization. Over its history, Webster claims more than 370 platform and add-on investments and 200+ combined years of operating and investing experience across its partners, signaling a mature, sector-specialist platform rather than a generalist allocator.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWaltham, United States
HQ citystring
Waltham
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare private equity, middle market investing, control buyout investments, healthcare services investing, portfolio company management
Industry1 code
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity
NAICS code3 codes
  • Portfolio Management and Investment Advice523940
  • Funds, Trusts, and Other Financial Vehicles525
  • Portfolio Management and Investment Advice52394
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Private Equity
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Fund Management
TypeManaged Services
Description

Webster Equity Partners generates revenue through traditional private equity fund management structures, including management fees and carried interest from fund investments.

websterequitypartners.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Webster Equity Partners is a private equity firm that invests in and develops branded consumer and healthcare services companies. The firm operates as a control investor, typically providing first institutional capital to profitable healthcare companies with $20M–$200M in revenue and $5–$20M+ EBITDA at entry, partnering with management to drive organic and acquisition-based growth toward $100M+ EBITDA.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Target companies with revenues of $20 million to $200 million
+2 more records
Product overview1 text field

Webster Equity Partners is a private equity firm that provides investment management services to institutional investors. The firm does not offer a unified product or platform but rather manages a portfolio of healthcare-focused portfolio companies through its investment funds. The portfolio comprises 25+ companies across diverse healthcare sectors including risk adjustment solutions (Advantmed), behavioral health (Discovery Behavioral Health, Oceans Healthcare), hospice and home health (Bristol Hospice, Honor), specialty pharmacy (Belmar Pharma Solutions), clinical research (CenExel), medical devices (Orthofeet), radiopharmaceuticals (PharmaLogic), fertility services (Pinnacle Fertility), and various physician practice management organizations. The firm's investment strategy targets healthcare companies with revenues of $20 million to $200 million, focusing on physician practice management, post-acute care, value-based care, women's and children's health, behavioral health, and pharma services.

Product and service6 records
1Webster Equity Partners Fund I
CategoryPrivate Equity Fund
Description

First private equity fund from Webster Equity Partners, deploying $10.5M in committed capital toward healthcare investments.

2Webster Equity Partners Fund II
CategoryPrivate Equity Fund
Description

Second private equity fund, raising $204.9M to deploy into healthcare sector investments.

3Webster Equity Partners Fund III
CategoryPrivate Equity Fund
Description

Third private equity fund, raising $416M for healthcare-focused investments.

4Webster Equity Partners Fund IV
CategoryPrivate Equity Fund
Description

Fourth private equity fund, raising $875M for healthcare sector investments.

5Webster Equity Partners Fund V
CategoryPrivate Equity Fund
Description

Fifth private equity fund, raising $1.7B for healthcare-focused investments.

6Webster Equity Partners Fund VI
CategoryPrivate Equity Fund
Description

Sixth private equity fund, raising $1.8B to deploy into healthcare sector investments; currently the active fund.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Middle-market PE firm with a dedicated healthcare franchise and active platform/add-on strategy in healthcare services. Closely mirrors Webster's mid-market healthcare control-investor approach.

TypeDirect peer
Description

Chicago-based PE firm with a long healthcare services track record (Cedar Gate, Maravai, GreenSlate). Comparable to Webster for sector mandate, founder-led-model, and mid-to-large healthcare control deals.

TypeBroad incumbent
Description

Large global PE firm with a substantial healthcare practice spanning provider services, payors, and life sciences. Overlaps with Webster on healthcare services investing but at significantly larger check sizes and broader geographic scope.

TypeDirect peer
Description

Growth-oriented PE firm with deep healthcare services franchise (risk-bearing primary care, payors, services). Comparable to Webster on healthcare-focused thesis and growth-equity-to-control orientation.

TypeDirect peer
Description

Healthcare-focused middle-market PE firm based in Chicago making control investments in healthcare services and products. Highly comparable to Webster by sector mandate, deal size, and operating-partner model.

TypeDirect peer
Description

Healthcare-focused middle-market PE firm with a track record of healthcare services and pharma services investments. Directly comparable to Webster on healthcare specialization and mid-market control deals.

TypeDirect peer
Description

Healthcare and technology-focused PE firm founded in 1979 with a long-standing healthcare-only investing franchise. Closely comparable to Webster in sector specialization, control-investor approach, and long-duration fund model.

TypeBroad incumbent
Description

Large multi-strategy PE firm with a dedicated Bain Capital Life Sciences and healthcare practice. Comparable to Webster on healthcare focus and operating partner approach, but operates at materially larger scale and broader sector mandate.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A11 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment6 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Webster Equity Partners

Healthcare Private Equitywebsterequitypartners.com

What Webster Equity Partners does

Webster Equity Partners is a Waltham, Massachusetts-based private equity firm founded in 2003 by Donald Steiner that invests exclusively in the branded consumer and healthcare services sectors, with current strategy focused entirely on healthcare. The firm operates a control-investor model, targeting profitable healthcare companies with $20 million to $200 million in revenue and $5 million to $20 million+ EBITDA at entry, typically as the first institutional capital provider. Its portfolio spans more than 25 current companies across risk adjustment (Advantmed), behavioral health (Discovery Behavioral Health, Oceans Healthcare), hospice and home health (Bristol Hospice, Honor), specialty pharmacy (Belmar Pharma Solutions), clinical research (CenExel), medical devices (Orthofeet), radiopharmaceutical CDMO (PharmaLogic), fertility (Pinnacle Fertility), physician practice management (One GI, CVAUSA, Medrina), and adjacent services, with a stated goal of growing portfolio companies to $100M+ EBITDA.

The firm earns revenue through traditional private equity fund management, collecting management fees and carried interest on six successive flagship funds that have grown from $10.5 million (Fund I, 2003) to $1.8 billion (Fund VI, March 2026), with total assets under management of $10.1 billion as of December 31, 2025. Webster supports portfolio companies with Webster Operating Executives, a senior advisory bench drawn from prior CEO/CFO/COO roles at companies including Ralph Lauren, Gap, Guess, BCBG, Bain Capital, Morgan Stanley, Independence Blue Cross, and UnitedHealth Group. Go-to-market is direct and relationship-driven: deal flow sourced through proprietary outreach, healthcare executive networks, and banker relationships, while capital is raised privately from institutional limited partners through confidential offering memoranda and an LP portal.

The firm employs 11-50 staff across its Waltham headquarters and a secondary Palm Beach office, maintains a SEC-registered investment adviser entity (Webster Equity Partners, L.P.), and has rebranded in 2019 from "Webster" to "Webster Equity Partners" to reflect its healthcare specialization. Over its history, Webster claims more than 370 platform and add-on investments and 200+ combined years of operating and investing experience across its partners, signaling a mature, sector-specialist platform rather than a generalist allocator.

Webster Equity Partners firmographics

Firmographics
Name
Webster Equity Partners
Legal name
Webster Equity Partners, L.P.
Website
https://websterequitypartners.com
Company type
Private
Founded year
2003
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Webster Equity Partners industry classification

Industry
Product category
Healthcare Private Equity
NAICS
Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (52394)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANACAO
Multi-Sector / Generalist Growth Equity

Keywords

  • Healthcare private equity
  • Middle market investing
  • Control buyout investments
  • Healthcare services investing
  • Portfolio company management

Where Webster Equity Partners is headquartered

Location

Headquarters

HQ city
Waltham
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Webster Equity Partners business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Fund Management: Webster Equity Partners generates revenue through traditional private equity fund management structures, including management fees and carried interest from fund investments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Webster Equity Partners product offering

Product offering

Core offering

Webster Equity Partners is a private equity firm that invests in and develops branded consumer and healthcare services companies. The firm operates as a control investor, typically providing first institutional capital to profitable healthcare companies with $20M–$200M in revenue and $5–$20M+ EBITDA at entry, partnering with management to drive organic and acquisition-based growth toward $100M+ EBITDA.

Product overview

Webster Equity Partners is a private equity firm that provides investment management services to institutional investors. The firm does not offer a unified product or platform but rather manages a portfolio of healthcare-focused portfolio companies through its investment funds. The portfolio comprises 25+ companies across diverse healthcare sectors including risk adjustment solutions (Advantmed), behavioral health (Discovery Behavioral Health, Oceans Healthcare), hospice and home health (Bristol Hospice, Honor), specialty pharmacy (Belmar Pharma Solutions), clinical research (CenExel), medical devices (Orthofeet), radiopharmaceuticals (PharmaLogic), fertility services (Pinnacle Fertility), and various physician practice management organizations. The firm's investment strategy targets healthcare companies with revenues of $20 million to $200 million, focusing on physician practice management, post-acute care, value-based care, women's and children's health, behavioral health, and pharma services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Webster Equity Partners Fund I First private equity fund from Webster Equity Partners, deploying $10.5M in committed capital toward healthcare investments.
  • Webster Equity Partners Fund II Second private equity fund, raising $204.9M to deploy into healthcare sector investments.
  • Webster Equity Partners Fund III Third private equity fund, raising $416M for healthcare-focused investments.
  • Webster Equity Partners Fund IV Fourth private equity fund, raising $875M for healthcare sector investments.
  • Webster Equity Partners Fund V Fifth private equity fund, raising $1.7B for healthcare-focused investments.
  • Webster Equity Partners Fund VI Sixth private equity fund, raising $1.8B to deploy into healthcare sector investments; currently the active fund.

Quantifiable outcome

  • Target companies with revenues of $20 million to $200 million
  • +2 more outcomes

Companies that use Webster Equity Partners

Customer profile

Segments1 record

Ideal customer profiles2 records

Webster Equity Partners technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Webster Equity Partners partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Webster Equity Partners competitors and assessment

Company assessment

Direct peers

  • Audax Group: Middle-market PE firm with a dedicated healthcare franchise and active platform/add-on strategy in healthcare services. Closely mirrors Webster's mid-market healthcare control-investor approach.
  • GTCR: Chicago-based PE firm with a long healthcare services track record (Cedar Gate, Maravai, GreenSlate). Comparable to Webster for sector mandate, founder-led-model, and mid-to-large healthcare control deals.
  • New Mountain Capital: Growth-oriented PE firm with deep healthcare services franchise (risk-bearing primary care, payors, services). Comparable to Webster on healthcare-focused thesis and growth-equity-to-control orientation.
  • Linden Capital Partners: Healthcare-focused middle-market PE firm based in Chicago making control investments in healthcare services and products. Highly comparable to Webster by sector mandate, deal size, and operating-partner model.
  • Avista Capital Partners: Healthcare-focused middle-market PE firm with a track record of healthcare services and pharma services investments. Directly comparable to Webster on healthcare specialization and mid-market control deals.
  • Welsh, Carson, Anderson & Stowe: Healthcare and technology-focused PE firm founded in 1979 with a long-standing healthcare-only investing franchise. Closely comparable to Webster in sector specialization, control-investor approach, and long-duration fund model.

Broad incumbents

  • TPG Capital: Large global PE firm with a substantial healthcare practice spanning provider services, payors, and life sciences. Overlaps with Webster on healthcare services investing but at significantly larger check sizes and broader geographic scope.
  • Bain Capital: Large multi-strategy PE firm with a dedicated Bain Capital Life Sciences and healthcare practice. Comparable to Webster on healthcare focus and operating partner approach, but operates at materially larger scale and broader sector mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

Webster Equity Partners financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Webster Equity Partners leadership team

Management profile

Number of profiles

Profiles11 records

Webster Equity Partners funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Webster Equity Partners M&A and investment

M&A and investment

M&A11 records

Investments6 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Webster Equity Partners

What does Webster Equity Partners do?

Webster Equity Partners is a private equity firm that invests in and develops branded consumer and healthcare services companies. The firm operates as a control investor, typically providing first institutional capital to profitable healthcare companies with $20M–$200M in revenue and $5–$20M+ EBITDA at entry, partnering with management to drive organic and acquisition-based growth toward $100M+ EBITDA.

Is Webster Equity Partners a public or private company?

Webster Equity Partners is a private company. It is classified as private equity controlled and is currently operating.

When was Webster Equity Partners founded?

Webster Equity Partners was founded in 2003. It employs 11 to 50 people.

Where is Webster Equity Partners based?

Webster Equity Partners is headquartered in Waltham, United States, in the North America region.

How does Webster Equity Partners make money?

One revenue line is on record: fund Management.

Who are Webster Equity Partners's main competitors?

Direct peers on record are Audax Group, GTCR, New Mountain Capital, Linden Capital Partners, Avista Capital Partners and Welsh, Carson, Anderson & Stowe. Broad incumbents are TPG Capital and Bain Capital.

Does Webster Equity Partners have an API?

No public API is recorded for Webster Equity Partners.

What industry is Webster Equity Partners in?

Webster Equity Partners's product category is Healthcare Private Equity. Its primary akta.pro industry code is FSANACAO, Multi-Sector / Generalist Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireINVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – LFCR, LSTA, FSHP and BWIN - IS IT A FAIR DEAL FOR YOU?Monteverde & Associates PC, a class action securities firm, is investigating four merger deals: Lifecore Biomedical's sale to Webster Equity Partners, Lisata Therapeutics' merger with Marea, Flag Ship's merger with Bluechip, and Baldwin Insurance's sale to Sequence AI. The firm asks shareholders whether these deals are fair, citing specific cash per share amounts.PR NewswireAre RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?Halper Sadeh LLC is investigating four proposed transactions: RXO's sale to C.H. Robinson, PTC's sale to Schneider Electric, Lifecore's sale to Webster Equity Partners, and WaFd's merger with EverBank. The deals involve cash and stock consideration, with WaFd shareholders expected to own 40.8% of the combined company.Ticker ReportLifecore agrees to acquisition with CVRs up to $160 millionLifecore Biomedical agreed to be acquired by Webster Equity Partners, paying $6.28 per share in cash plus one non-tradable CVR per share. The deal is valued at up to $663.7 million, with CVRs potentially adding $160 million based on milestones. Closing is expected in Q4 2026, subject to approvals.Business Wire BlogLifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCRKahn Swick & Foti, LLC is investigating the proposed sale of Lifecore Biomedical to Webster Equity Partners, seeking to determine whether the $6.28 per share consideration and the process are adequate. The firm invites shareholders to contact them without obligation or cost if they believe the transaction undervalues the company.MorningstarLifecore Biomedical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lifecore Biomedical, Inc. - LFCRKahn Swick & Foti, LLC is investigating the proposed sale of Lifecore Biomedical to Webster Equity Partners, offering shareholders $6.28 per share. The firm seeks to determine whether the consideration and process are adequate, or if the deal undervalues the company.Pulse 2.0Lifecore Biomedical To Be Acquired By Webster Equity Partners In Deal Valued At Up To $663.7 MillionLifecore Biomedical agreed to be acquired by Webster Equity Partners in a deal valued at up to $663.7 million, contingent on performance milestones. The cash price is $6.28 per share, with CVRs adding up to $160 million, for a total of up to $9.67 per share. Closing is expected in Q4 2026.MorningstarAre LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?Halper Sadeh LLC is investigating Lifecore Biomedical, Integer Holdings, First Hawaiian, and Indivior Pharmaceuticals for potential securities law violations and fiduciary breaches. The firm claims insiders may receive substantial benefits not available to ordinary shareholders and is seeking increased consideration or additional disclosures on a contingent fee basis.Seeking AlphaLifecore Biomedical to be acquired by Webster Equity Partners (LFCR:NASDAQ)Lifecore Biomedical agreed to be acquired by Webster Equity Partners in a deal valued up to $663.7 million, with $6.28 per share in cash plus a contingent value right. The transaction includes a 30-day go-shop period and is expected to close in the fourth quarter of 2026.Stock TitanLifecore agrees to Webster acquisition worth up to $663.7MLifecore Biomedical agreed to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, with common stockholders receiving $6.28 per share in cash at closing. The deal includes contingent value rights for up to $160 million in aggregate cash payments, and the transaction is expected to close in Q4 2026.LifecoreLifecore Biomedical to be Acquired by Webster Equity PartnersLifecore Biomedical agreed to be acquired by Webster Equity Partners in a transaction valued up to $663.7 million, with common stockholders receiving $6.28 per share in cash at closing. The deal includes contingent value rights for up to $160 million in performance milestone payments, and the transaction is expected to close in Q4 2026.